| Literature DB >> 32608968 |
Xianxian Zhao1, Leili Zeng1,2, Qiang Mei1,3, Yang Luo4,5.
Abstract
Extracellular vesicles (EVs) are emerging as promising biomarkers for cancer diagnosis and therapy. Recognizing low-abundance EVs from clinical samples in an easy-to-operate way is highly desired but remains a challenge. Herein, we established an allosteric probe-initiated dual cycle amplification-assisted CRISPR-Cas12a (AID-Cas) platform for sensitive detection of EVs in a wash-free way. In AID-Cas, the allosteric probe can specifically recognize and bind with target EVs and thus initiate the following dual-cycle amplification. Subsequently, the amplified products were transcribed to generate numerous single-stranded RNAs, which could work as crRNA to trigger the trans-cleavage of CRISPR-Cas12a. Consequently, the proposed approach achieved a good linear response to extracted EVs in a concentration range from 102 to 106 particles/μL. Because of its high sensitivity, together with its wash-free convenience, the proposed strategy could have promising clinical potentials for early diagnosis of cancers.Entities:
Keywords: CD63 aptamer; CRISPR-Cas12a; allosteric probe; extracellular vesicles; trans-cleavage; wash-free
Mesh:
Substances:
Year: 2020 PMID: 32608968 DOI: 10.1021/acssensors.0c00944
Source DB: PubMed Journal: ACS Sens ISSN: 2379-3694 Impact factor: 7.711